SCHEMBL30559883

SCHEMBL30559883

O=C(O)N1CCNCC1c1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP19 O94966 2/20 0.39
DPP4 P27487 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
CHRNB2 P17787 2/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CHRNA4 P43681 2/20 0.38
CHRNA7 P36544 1/20 0.38
ADRB2 P07550 1/20 0.38
NCF1 P14598 1/20 0.38
PLD1 Q13393 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RIPK1 Q13546 2/20 0.37
PARP1 P09874 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16462634 0.87 MAOA (0.42) USP19DPP4DPP7CHRNB2CHRNB4
SCHEMBL20528485 0.86 DPP4 (0.46) USP19DPP4DPP7RIPK1HTR2A
SCHEMBL21801033 0.86 DPP4 (0.46) USP19DPP4DPP7RIPK1HTR2A
SCHEMBL2935422 0.86 DPP4 (0.46) USP19DPP4DPP7RIPK1HTR2A
Hydrochloric Acid SCHEMBL9258072 0.84 DPP4 (0.46) USP19DPP4DPP7RIPK1HTR2A
SCHEMBL3314580 0.83 DPP4 (0.53) DPP4DPP7ALDH1A1MAPTHTR2A
SCHEMBL38659223 0.83 KDM4E (0.45) USP19CHRNB2CHRNA4CHRNA7ALDH1A1
Hydrochloric Acid SCHEMBL2234958 0.82 USP19 (0.45) USP19
SCHEMBL16261916 0.82 DPP4 (0.41) USP19DPP4DPP7MAOAMAOB
SCHEMBL15636064 0.82 DPP4 (0.41) USP19DPP4DPP7HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111566102-B Substituted pyrrolopyridines as activin receptor-like kinase inhibitors 缆图药品公司 2023-09-08 CN disclosed